Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2

Annals of the Rheumatic Diseases

Volumn 72, Issue 6, 2013, Pages 1080-1088

  Gao, Wei ^a   Sweeney, Catherine ^a   Walsh, Ceara ^a   Rooney, Peadar ^a   McCormick, Jennifer ^a   Veale, Douglas J ^a   Fearon, Ursula ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; DELTA LIKE LIGAND 4; GAMMA SECRETASE INHIBITOR; GELATINASE A; GELATINASE B; GROWTH FACTOR; HES RELATED TRANSCRIPTIONAL REPRESSOR 1; HES RELATED TRANSCRIPTIONAL REPRESSOR 2; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH4 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT BIOPSY; MALE; MICROVASCULAR ENDOTHELIAL CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; WESTERN BLOTTING; WOUND HEALING;

AUTOIMMUNE DISEASES; INFLAMMATION; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OSTEOARTHRITIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877625111     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201978     Document Type: Article

References (85)

1. Akil M, Amos RS. ABC of rheumatology. Rheumatoid arthritis - I: clinical features and diagnosis. BMJ 1995;310:587-90.
2. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell 1996;87:1153-5. (Pubitemid 27010098)
3. Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003;62(Suppl 2):ii60-7.
4. Reece RJ, Canete JD, Parsons WJ, et al. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999;42:1481-4. (Pubitemid 30265607)
5. Fearon U, Griosios K, Fraser A, et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003;30:260-8. (Pubitemid 36152587)
6. Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-56. (Pubitemid 24111088)
7. Scott BB, Zaratin PF, Colombo A, et al. Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts. J Rheumatol 2002;29:230-9. (Pubitemid 34118766)
8. Canete JD, Pablos JL, Sanmarti R, et al. Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum 2004;50:1636-41. (Pubitemid 38608086)
9. Frye CA, Yocum DE, Tuan R, et al. An in vitro model for studying mechanisms underlying synoviocyte-mediated cartilage invasion in rheumatoid arthritis. Pathol Oncol Res 1996;2:157-66.
10. Rosengren S, Corr M, Boyle DL. Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes. Arthritis Res Ther 2010;12:R65.
11. Braverman IM, Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol 1977;68:53-60. (Pubitemid 8019017)
12. Markham T, Mullan R, Golden-Mason L, et al. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J Am Acad Dermatol 2006;54:1003-12.
13. Cordiali-Fei P, Trento E, D'Agosto G, et al. Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha. J Autoimmune Dis 2006;3:5.
14. Veale D, Yanni G, Rogers S, et al. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993;36:893-900. (Pubitemid 23201103)
15. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25. (Pubitemid 27076453)
16. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-80. (Pubitemid 27010101)
17. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998;282:468-71. (Pubitemid 28483672)
18. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60. (Pubitemid 27450643)
19. Asahara T, Chen D, Takahashi T, et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998;83:233-40. (Pubitemid 28371312)
20. Holash J, Maisonpierre PC, Compton D, et al . Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994-8. (Pubitemid 29309448)
21. Zagzag D, Hooper A, Friedlander DR, et al. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 1999;159:391-400. (Pubitemid 29485225)
22. Uchida T, Nakashima M, Hirota Y, et al. Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation. Ann Rheum Dis 2000;59:607-14. (Pubitemid 30617086)
23. Shahrara S, Volin MV, Connors MA, et al. Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res 2002;4:201-8. (Pubitemid 34460760)
24. Malik NM, Jin P, Raatz Y, et al. Regulation of the angiopoietin-Tie ligand-receptor system with a novel splice variant of Tie1 reduces the severity of murine arthritis. Rheumatology (Oxford) 2010;49:1828-39.
25. Chen Y, Donnelly E, Kobayashi H, et al. Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. Arthritis Rheum 2005;52:1585-94. (Pubitemid 40663951)
26. Saber T, Veale DJ, Balogh E, et al. Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis. PLoS One 2011;6:e23540.
27. Milner LA, Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood 1999;93:2431-48. (Pubitemid 29181173)
28. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-6. (Pubitemid 29291335)
29. Gridley T. Notch signaling in vascular development and physiology. Development 2007;134:2709-18. (Pubitemid 47305050)
30. Iso T, Hamamori Y, Kedes L. Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 2003;23:543-53. (Pubitemid 36438065)
31. Sullivan DC, Bicknell R. New molecular pathways in angiogenesis. Br J Cancer 2003;89:228-31. (Pubitemid 36976305)
32. Liu ZJ, Shirakawa T, Li Y, et al. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 2003;23:14-25. (Pubitemid 36008497)
33. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005;97:512-23. (Pubitemid 41361741)
34. Li L, Huang GM, Banta AB, et al. Cloning, characterization, and the complete 56.8-kilobase DNA sequence of the human NOTCH4 gene. Genomics 1998;51:45-58. (Pubitemid 28373372)
35. Uyttendaele H, Marazzi G, Wu G, et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 1996;122:2251-9. (Pubitemid 26235824)
36. Knust E, Dietrich U, Tepass U, et al. EGF homologous sequences encoded in the genome of Drosophila melanogaster, and their relation to neurogenic genes. EMBO J 1987;6:761-6.
37. Fleming RJ, Scottgale TN, Diederich RJ, et al. The gene Serrate encodes a putative EGF-like transmembrane protein essential for proper ectodermal development in Drosophila melanogaster. Genes Dev 1990;4:2188-201. (Pubitemid 120034524)
38. Lindsell CE, Shawber CJ, Boulter J, et al. Jagged: a mammalian ligand that activates Notch1. Cell 1995;80:909-17.
39. Weinmaster G. Notch signaling: direct or what? Curr Opin Genet Dev 1998;8:436-42. (Pubitemid 28412461)
40. Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol 2000;228:151-65. (Pubitemid 32011983)
41. Davis RL, Turner DL. Vertebrate hairy and enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 2001;20:8342-57. (Pubitemid 34121905)
42. Ando K, Kanazawa S, Tetsuka T, et al. Induction of Notch signaling by tumor necrosis factor in rheumatoid synovial fibroblasts. Oncogene 2003;22:7796-803. (Pubitemid 37485538)
43. Ishii H, Nakazawa M, Yoshino S, et al. Expression of notch homologues in the synovium of rheumatoid arthritis and osteoarthritis patients. Rheumatol Int 2001;21:10-14. (Pubitemid 32835362)
44. Kijima M, Iwata A, Maekawa Y, et al. Jagged1 suppresses collagen-induced arthritis by indirectly providing a negative signal in CD8+ T cells. J Immunol 2009;182:3566-72.
45. Nakazawa M, Ishii H, Aono H, et al. Role of Notch-1 intracellular domain in activation of rheumatoid synoviocytes. Arthritis Rheum 2001;44:1545-54. (Pubitemid 32642217)
46. Jiao Z, Wang W, Xu H, et al. Engagement of activated Notch signalling in collagen II-specific T helper type 1 (Th1)- and Th17-type expansion involving Notch3 and Delta-like1. Clin Exp Immunol 2011;164:66-71.
47. Ng CT, Biniecka M, Kennedy A, et al. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 2010;69:1389-95.
48. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
49. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
50. Feliers D, Chen X, Akis N, et al. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int 2005;68:1648-59. (Pubitemid 43169910)
51. Dunk C, Shams M, Nijjar S, et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 2000;156:2185-99. (Pubitemid 30641785)
52. Gao W, Sweeney C, Connolly M, et al. Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 2012;64:2104-13.
53. Kennedy A, Ng CT, Chang TC, et al. Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia. Arthritis Rheum 2011;63:923-32.
54. Connolly M, Veale DJ, Fearon U. Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis. Ann Rheum Dis 2011;70:1296-303.
55. Szekanecz Z, Koch AE. Endothelial cells in inflammation and angiogenesis. Curr Drug Targets Inflamm Allergy 2005;4:319-23. (Pubitemid 40873118)
56. Cho ML, Jung YO, Moon YM, et al. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett 2006;103:159-66. (Pubitemid 43162931)
57. Honorati MC, Neri S, Cattini L, et al. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage 2006;14:345-52.
58. Cho ML, Ju JH, Kim HR, et al. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 2007;108:121-8.
59. Akhavani MA, Madden L, Buysschaert I, et al. Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther 2009;11:R64.
60. Kennedy A, Ng CT, Biniecka M, et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010;62:711-21.
61. DeBusk LM, Chen Y, Nishishita T, et al. Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor alpha-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 2003;48:2461-71. (Pubitemid 37129423)
62. Izquierdo E, Canete JD, Celis R, et al. Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS One 2009;4:e8131.
63. Hashizume H, Falcon BL, Kuroda T, et al. Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth. Cancer Res 2010;70:2213-23.
64. Peters S, Cree IA, Alexander R, et al. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability. Cytokine 2007;40:144-50. (Pubitemid 350180531)
65. Oshima Y, Oshima S, Nambu H, et al. Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive. FASEB J 2005;19:963-5. (Pubitemid 40827718)
66. De Smet F, Segura I, De Bock K, et al. Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler Thromb Vasc Biol 2009;29:639-49.
67. Zhang J, Fukuhara S, Sako K, et al. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. J Biol Chem 2011;286:8055-66.
68. Liu H, Zhang W, Kennard S, et al . Notch3 is critical for proper angiogenesis and mural cell investment. Circ Res 2010;107:860-70.
69. Morrow D, Cullen JP, Cahill PA, et al. Cyclic strain regulates the Notch/CBF-1 signaling pathway in endothelial cells: role in angiogenic activity. Arterioscler Thromb Vasc Biol 2007;27:1289-96. (Pubitemid 46809417)
70. Johnson BA, Haines GK, Harlow LA, et al. Adhesion molecule expression in human synovial tissue. Arthritis Rheum 1993;36:137-46. (Pubitemid 23059324)
71. Connolly M, Marrelli A, Blades M, et al. Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol 2010;184:6427-37.
72. Bayless KJ, Davis GE. The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci 2002;115:1123-36. (Pubitemid 34272478)
73. Chapados R, Abe K, Ihida-Stansbury K, et al. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling. Circ Res 2006;99:837-44. (Pubitemid 44556382)
74. Philippova M, Ivanov D, Allenspach R, et al. RhoA and Rac mediate endothelial cell polarization and detachment induced by T-cadherin. FASEB J 2005;19:588-90. (Pubitemid 40471253)
75. Davis GE, Bayless KJ. An integrin and Rho GTPase-dependent pinocytic vacuole mechanism controls capillary lumen formation in collagen and fibrin matrices. Microcirculation 2003;10:27-44. (Pubitemid 39004235)
76. Hoang MV, Whelan MC, Senger DR. Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc Natl Acad Sci USA 2004;101:1874-9. (Pubitemid 38228984)
77. Piggott K, Deng J, Warrington K, et al. Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation 2011;123:309-18.
78. Perez-Cabezas B, Naranjo-Gomez M, Bastos-Amador P, et al. Ligation of Notch receptors in human conventional and plasmacytoid dendritic cells differentially regulates cytokine and chemokine secretion and modulates Th cell polarization. J Immunol 2011;186:7006-15.
79. Jiao Z, Wang W, Ma J, et al. Notch signaling mediates TNF-alpha-induced IL-6 production in cultured fibroblast-like synoviocytes from rheumatoid arthritis. Clin Dev Immunol 2012;2012:350209.
80. Curry CL, Reed LL, Golde TE, et al. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene 2005;24:6333-44. (Pubitemid 41486467)
81. Ghaleb AM, Aggarwal G, Bialkowska AB, et al. Notch inhibits expression of the Kruppel-like factor 4 tumor suppressor in the intestinal epithelium. Mol Cancer Res 2008;6:1920-7.
82. Ferrari-Toninelli G, Bonini SA, Uberti D, et al. Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells. Neuro Oncol 2010;12:1231-43.
83. Ebos JM, Lee CR, Cruz-Munoz W, et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009;15:232-9.
84. Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009;15:220-31.
85. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62. (Pubitemid 40093472)